1295 related articles for article (PubMed ID: 12281276)
21. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
22. [The eye and hormones: vascular disorders associated with combined oral contraceptives and pregnancy].
Villatte-cathelineau B
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):147-52. PubMed ID: 12280201
[TBL] [Abstract][Full Text] [Related]
23. [Hepatic and biliary repercussions of estrogens: dose or duration of treatment effect].
Hecht Y
Contracept Fertil Sex (Paris); 1991 May; 19(5):403-8. PubMed ID: 12316961
[TBL] [Abstract][Full Text] [Related]
24. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
25. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
Gaspard U; Dubois M
Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
[TBL] [Abstract][Full Text] [Related]
26. [Cerebrovascular complications of oral contraceptives. Review of the literature; report of 2 cases].
Amidjogbe B; Ngom A; Traore M; Moreau JC; Bah MD; Ndiaye IP; Correa P
Afr Med; 1986 Apr; 25(240):185-8. PubMed ID: 12269210
[TBL] [Abstract][Full Text] [Related]
27. [How to choose an oral contraceptive in 1984].
Rozenbaum H
Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609
[TBL] [Abstract][Full Text] [Related]
28. [Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases (author's transl)].
Henrion R; Laveissiere MN
Contracept Fertil Sex (Paris); 1982 Oct; 10(10):653-7. PubMed ID: 12338447
[TBL] [Abstract][Full Text] [Related]
29. An update on the pill.
Initiatives Popul; 1983; 7(3):2-15. PubMed ID: 12339841
[TBL] [Abstract][Full Text] [Related]
30. [Disease and contraception. Recent aspects].
Rozenbaum H
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):431-6. PubMed ID: 12280211
[TBL] [Abstract][Full Text] [Related]
31. Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptives.
Wiegratz I; Kuhl H
Treat Endocrinol; 2002; 1(6):372-86. PubMed ID: 15832490
[TBL] [Abstract][Full Text] [Related]
32. [Hypertension, heart disease and combined oral contraceptives].
Lombrail P; Cathelineau G
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):127-30. PubMed ID: 12280198
[TBL] [Abstract][Full Text] [Related]
33. [Choosing contraception for adolescents].
Wemeau-jacquemont C
NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
[TBL] [Abstract][Full Text] [Related]
34. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
Boyet F
Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
[TBL] [Abstract][Full Text] [Related]
35. Metabolic effects of oral contraceptives: fact vs. fiction.
Contracept Rep; 1996 Jan; 6(6):4-14. PubMed ID: 12320011
[TBL] [Abstract][Full Text] [Related]
36. Oral contraceptive and dermatology.
Chowdhury DS
Calcutta Med J; 1973; 70(7-8):187-8. PubMed ID: 12306910
[TBL] [Abstract][Full Text] [Related]
37. Present status of oral contraceptives: 1. effectiveness; basis for selection; side effects; metabolic changes.
Kistner RW
Drug Ther (NY); 1971 Dec; 1(12):14-29. PubMed ID: 12306285
[TBL] [Abstract][Full Text] [Related]
38. [Vascular disease and hormonal treatment--epidemiology].
Vessey MP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
[TBL] [Abstract][Full Text] [Related]
39. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
40. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
